ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,767Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 285

$973K Total Retail Price of All Prescriptions

Rank: 1 out of 285

471 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 471 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

14% of this provider’s 471 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

2% of this provider’s 14,790 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $75 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
FUROSEMIDE 613 572 1 6
WARFARIN SODIUM 597 506 2 7
HYDROCODONE-ACETAMINOPHEN 581 456 S3 3 51
LEVOTHYROXINE SODIUM 568 517 4 29
AMLODIPINE BESYLATE 563 505 5 4
OMEPRAZOLE 482 414 6 35
SIMVASTATIN 473 396 7 8
LOVASTATIN 470 399 8 38
METOPROLOL SUCCINATE 422 395 9 1
SPIRONOLACTONE 309 296 10 24
GABAPENTIN 295 237 11 66
DIGOXIN 278 254 12 12
METFORMIN HCL 265 212 13 41
METOPROLOL TARTRATE 259 236 14 3
LOSARTAN-HYDROCHLOROTHIAZIDE 258 243 15 42
LISINOPRIL 255 170 16 5
CARVEDILOL 253 231 17 9
LOSARTAN POTASSIUM 243 221 18 17
ATORVASTATIN CALCIUM 238 201 19 2
ZOLPIDEM TARTRATE 237 160 20 54
NEXIUM 219 144 21 64
GLIPIZIDE 214 158 22 69
MELOXICAM 197 183 23 102
TRAMADOL HCL 196 128 24 86
JANUVIA 185 156 25 89
QUINAPRIL HCL 155 124 26 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 152 102 27 39
DONEPEZIL HCL 141 141 28 78
ISOSORBIDE MONONITRATE ER 139 134 29 16
NAMENDA 134 134 30 101
TAMSULOSIN HCL 132 119 31 77
POTASSIUM CHLORIDE 129 114 32 28
LABETALOL HCL 126 106 33 59
DIOVAN 121 114 34 15
BENICAR HCT 118 106 35 61
SERTRALINE HCL 114 87 36 91
ALLOPURINOL 112 96 37 60
ATENOLOL 104 65 38 10
GLIPIZIDE ER 102 102 39 105
DILTIAZEM 24HR CD 102 102 39 30
CLOPIDOGREL 101 101 41 13
PREDNISONE 100 79 42 106
CRESTOR 100 68 42 11
CITALOPRAM HBR 98 84 44 87
PROAIR HFA 97 58 45 122
ESCITALOPRAM OXALATE 95 69 46 83
MECLIZINE HCL 92 77 47 123
CYCLOBENZAPRINE HCL 90 54 R 48 124
PROPAFENONE HCL 89 83 49 81
VESICARE 88 53 50 126
HYDROCHLOROTHIAZIDE 87 84 51 14
LIPITOR 87 71 51 22
TRAZODONE HCL 81 52 53 109
AMITRIPTYLINE HCL 81 61 R 53 131
SINGULAIR 81 76 53 131
DIOVAN HCT 79 79 56 37
CYMBALTA 78 49 57 113
TRICOR 75 58 58 56
ADVAIR DISKUS 75 67 58 108
JANTOVEN 75 57 58 46
PAROXETINE HCL 74 51 61 134
ZAFIRLUKAST 74 62 61 134
RANITIDINE HCL 73 60 63 136
SYNTHROID 71 62 64 90
CELEBREX 69 55 65 94
HYDROXYZINE HCL 69 55 R 65 138
ACTONEL 65 65 67 140
MIRTAZAPINE 63 52 68 87
ZETIA 62 62 69 21
PRAVASTATIN SODIUM 61 53 70 19
LACTULOSE 60 55 71 144
QUINAPRIL-HYDROCHLOROTHIAZIDE 60 60 71 144
CARISOPRODOL 58 23 R 73 148
PLAVIX 58 58 73 18
LIDODERM 55 52 75 149
NAPROXEN 55 51 75 149
ACTOS 54 47 77 119
INDAPAMIDE 54 50 77 118
PANTOPRAZOLE SODIUM 54 42 77 63
COMBIVENT 53 39 80 156
COUMADIN 51 51 81 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.